|
|
Volumn 468, Issue 7322, 2010, Pages 354-
|
|
Good news for 'good' cholesterol
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANACETRAPIB;
C REACTIVE PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR;
DALCETRAPIB;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MK 0524A;
NICOTINIC ACID;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
RVX 208;
TORCETRAPIB;
UNCLASSIFIED DRUG;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG SAFETY;
HEART DISEASE;
HUMAN;
NOTE;
PRIORITY JOURNAL;
RISK REDUCTION;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
C-REACTIVE PROTEIN;
CHOLESTEROL ESTER TRANSFER PROTEINS;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CLINICAL TRIALS AS TOPIC;
HEART DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
OXAZOLIDINONES;
QUINOLINES;
SULFHYDRYL COMPOUNDS;
|
|
EID: 78549285635
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/468354a Document Type: Note |
|
Times cited : (2)
|
|
References (2)
|
